China’s drug industry pivots to AI-powered candidates to drive next wave of deals
After China’s cross-border deals for innovative drugs hit a record US$110 billion in the first half of 2026, the sector is now pivoting towards artificial intelligence-powered candidates to drive the next wave of transactions. China accounted for about 30 per cent of all new drugs currently under development worldwide, ranking second globally, according to Lan Gongtao, deputy director general of the Department of Drug Registration at the National Medical Products Administration. China’s...
Record details
Published: 13 July 2026
Source: SCMP Tech (HK/CN)
Category: News
Topics: Healthcare
Retrieved: 14 July 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
Chinese medical device makers push into Europe as anti-corruption squeeze bites at home
SCMP Tech (HK/CN) · 14 July 2026
Chinese biotech giant WuXi AppTec sees first-half earnings surge amid US scrutiny
SCMP Tech (HK/CN) · 3 August 2026
China’s ‘brain chip’ drive accelerates with slew of state-backed initiatives
SCMP Tech (HK/CN) · 13 August 2026
China’s massive AI rollout - podcast
The Guardian · 13 July 2026
China Life sets up semiconductor fund amid Beijing’s call for ‘patient’ capital
SCMP Tech (HK/CN) · 12 July 2026
China completes world’s first commercial brain-computer interface implant
SCMP Tech (HK/CN) · 15 July 2026
How to cite this record
ethics.ai (13 July 2026), “China’s drug industry pivots to AI-powered candidates to drive next wave of deals,” evidence record 2907, https://ethics.ai/record/2907 (originally published by SCMP Tech (HK/CN)).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.